LogoPressRelease.jpg
Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern Time
10 mai 2021 13h30 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year Period
06 mai 2021 16h05 HE | Fluidigm Corporation
Forecasting underlying base business growth of 16–17% supported by new product innovation SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an...
Luminate.png
Empire State Development Announces the 10 Finalists Selected for Round 4 of Luminate NY Accelerator Competition
16 mars 2021 11h28 HE | Luminate
$25 Million Luminate NY Initiative Continues to Bring the Best Startups with Optics, Photonics, and Imaging Technologies to the Finger Lakes Region to Tap World Class Resources and Grow the Economy ...
Imagin Medical LOGO.jpg
IMAGIN MEDICAL CLOSES SECOND TRANCHE OF CONVERTIBLE NOTE OFFERING
18 févr. 2021 08h30 HE | Imagin Medical Inc.
Vancouver, B.C. and Boston, MA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) (“Imagin” or the...
Imagin Medical LOGO.jpg
Imagin Medical Engages Torrey Hills Capital
20 janv. 2021 08h30 HE | Imagin Medical Inc.
VANCOUVER, British Columbia, and BOSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (FSE: DPD2) ("Imagin" or the "Company") is pleased to...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Financial Results
07 janv. 2021 16h02 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
TeraRecon Expands Change Healthcare Distribution Agreement Adding AI Subscription
30 nov. 2020 05h00 HE | TeraRecon, Inc
DURHAM, N.C., Nov. 30, 2020 (GLOBE NEWSWIRE) -- TeraRecon, the leading provider of AI-driven advanced visualization solutions, today announced the expansion of their distribution offering to Change...
TeraRecon Launches NVIDIA-Powered Clinical Training Cloud for Global Education
30 nov. 2020 05h00 HE | TeraRecon, Inc
DURHAM, N.C., Nov. 30, 2020 (GLOBE NEWSWIRE) -- TeraRecon, the leading provider of AI-driven advanced visualization solutions, today announced the debut of their Clinical Training Cloud for...
TeraRecon Awarded Landmark Patent for Diagnostic Imaging Clinical Reporting with AI
29 nov. 2020 05h00 HE | TeraRecon, Inc
DURHAM, N.C., Nov. 29, 2020 (GLOBE NEWSWIRE) -- TeraRecon, the leading provider of AI-driven advanced visualization solutions, has been awarded an expansion of their patent-protected AI...
Reports and Data.jpeg-01
Breast Cancer Diagnostics Market to Reach USD 8,738.9 Million By 2027 | Reports And Data
25 nov. 2020 11h50 HE | Reports and Data
New York, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Growing awareness for early detection of breast cancer is one of the significant factors influencing the market growth. Market Size – USD 4,955.1 Million...